Pharmacyclics LLC v. Acerta Pharma B.V. et al

1:17-cv-01582 | Delaware District Court

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Division Wilmington
Judge Judge Richard G. Andrews
Filed Nov. 3, 2017
Terminated Oct. 23, 2019
Case Flags CLOSED, DISCOVERY-SRF, MEDIATION-CJB, PATENT, and VACANTJUDGESHIP-2017
Magistrate Judge Sherry R. Fallon
Nature of Suit 830 Patent
Cause 35:271 Patent Infringement
Jury Demand Plaintiff
Patents 9,079,908, 9,139,591, and 9,556,182
Last Updated: 1 year, 9 months ago Show Interactive Timeline
Filing Date # Docket Text
10/23/2019Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,079,908 B2; 9,139,591 B2; 9,556,182 B2. (Attachments: # 1 Order)(nms) (Entered: 10/23/2019)
10/23/2019
  • Motion to Dismiss (Demurrer)Granted
SO ORDERED Granting 178 Joint Stipulation of Dismissal With Prejudice (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 10/22/2019. (nms) (Entered: 10/23/2019)
10/22/2019STIPULATION of Dismissal with Prejudice, by AstraZeneca Pharmaceuticals LP. (Kraman, Pilar) Modified on 10/22/2019 (nms). (Entered: 10/22/2019)
9/13/2019REDACTED VERSION of 174 Stipulation to Stay, by Pharmacyclics LLC. (Tigan, Jeremy) Modified on 9/13/2019 (nms). (Entered: 09/13/2019)
9/10/2019NOTICE requesting Clerk to remove Galina Fomenkova as co-counsel. Reason for request: no longer with Williams & Connolly LLP. (Poff, Adam) (Entered: 09/10/2019)
9/10/2019
  • Order
[SEALED] ORDER Granting (101 in 18-cv-581-RGA, 174 in 17-cv-1582-RGA-SRF) Sealed Stipulation to Stay and Order. Signed by Judge Richard G. Andrews on 9/6/2019.This order has been emailed to local counsel. Associated Cases: 1:17-cv-01582-RGA-SRF, 1:18-cv-00581-RGA(nms) (Entered: 09/10/2019)
9/6/2019[SEALED] STIPULATION to Stay by Pharmacyclics LLC. (Tigan, Jeremy) (Entered: 09/06/2019)
8/7/2019
  • Order
MEMORANDUM ORDER: Providing claim construction for multiple terms in U.S. Patent Nos. 9,079,908, 9,139,591, and 9,556,182. Signed by Judge Richard G. Andrews on 8/7/2019. (nms) (Entered: 08/07/2019)
6/14/2019NOTICE OF SERVICE of Pharmacyclics LLC's Third Set of Requests to Defendants for the Production of Documents and Things (Nos. 121-131) filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 06/14/2019)
6/9/2019Official Transcript of Markman Hearing held on 5/8/19 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/1/2019. Redacted Transcript Deadline set for 7/10/2019. Release of Transcript Restriction set for 9/9/2019. (Triozzi, Heather) (Entered: 06/09/2019)
6/7/2019 NOTICE of Third Party Subpoenas to Michael Hostetler by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibits 1-2)(Poff, Adam) Modified on 6/7/2019 (nms). (Entered: 06/07/2019)
6/4/2019NOTICE OF SERVICE of 1) Hanqing Dongs Objections and Responses to Pharmacyclics LLCs Subpoena for Documents; 2) Lixin Fengs Objections and Responses to Pharmacyclics LLCs Subpoena for Documents; 3) Yingchuan Suns Objections and Responses to Pharmacyclics LLCs Subpoena for Documents; and 4) Qinghua Wengs Objections and Responses to Pharmacyclics LLCs Subpoena for Documents filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd..(Poff, Adam) (Entered: 06/04/2019)
6/3/2019NOTICE OF SERVICE of Non-Parties Francisco Salva and Drs. Ahmed Hamdy and Raquel Izumis Responses and Objections to Pharmacyclicss Document Subpoenas filed by Acerta Pharma B.V., Acerta Pharma LLC.(Dudash, Amy) (Entered: 06/03/2019)
5/22/2019167
  • Order
ORAL ORDER: The parties have advised that discovery disputes have arisen requiring judicial attention. The disputes are now REFERRED to Magistrate Judge Sherry R. Fallon. The parties shall promptly contact Judge Fallon's Chambers. Ordered by Judge Richard G. Andrews on 5/22/2019. (nms) (Entered: 05/22/2019)
5/22/2019NOTICE to Take Deposition of Dennis Demont on Date Mutually Agreeable to the Parties filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 05/22/2019)
5/21/2019NOTICE OF SERVICE of 1) Andrew Crews Objections and Responses to Pharmacyclics LLCs Subpoena for Documents; 2) Kenneth Foremans Objections and Responses to Pharmacyclics LLCs Subpoena for Documents; 3) Patricia Johnsons Objections and Responses to Pharmacyclics LLCs Subpoena for Documents; 4) Mark J. Mulvihills Objections and Responses to Pharmacyclics LLCs Subpoena for Documents; 5) Anthony Nigros Objections and Responses to Pharmacyclics LLCs Subpoena for Documents; 6) Arno Steinigs Objections and Responses to Pharmacyclics LLCs Subpoena for Documents; 7) Kathryn Stolzs Objections and Responses to Pharmacyclics LLCs Subpoena for Documents; 8) Brian Volks Objections and Responses to Pharmacyclics LLCs Subpoena for Documents; 9) Douglas Werners Objections and Responses to Pharmacyclics LLCs Subpoena for Documents; and 10) Jac Wijkmanss Objections and Responses to Pharmacyclics LLCs Subpoena for Documents filed by AstraZeneca Pharmaceuticals LP.(Kraman, Pilar) (Entered: 05/21/2019)
5/21/2019NOTICE OF SERVICE of 1) AstraZeneca Pharmaceuticals LP and Acerta Pharma B.V.s Objections to Pharmacyclics LLCs Subpoena for Documents to Third Party Cara Cesario; 2) AstraZeneca Pharmaceuticals LP and Acerta Pharma B.V.s Objections to Pharmacyclics LLCs Subpoena for Documents to Third Party Andrew Cooke; 3) AstraZeneca Pharmaceuticals LP and Acerta Pharma B.V.s Objections to Pharmacyclics LLCs Subpoena for Documents to Third Party Qun-Sheng Ji; 4) AstraZeneca Pharmaceuticals LP and Acerta Pharma B.V.s Objections to Pharmacyclics LLCs Subpoena for Documents to Third Party Gilda Mak; 5) AstraZeneca Pharmaceuticals LP and Acerta Pharma B.V.s Objections to Pharmacyclics LLCs Subpoena for Documents to Third Party Matthew OConnor; and 6) AstraZeneca Pharmaceuticals LP and Acerta Pharma B.V.s Objections to Pharmacyclics LLCs Subpoena for Documents to Third Party Izabela Sujka filed by AstraZeneca Pharmaceuticals LP.(Kraman, Pilar) (Entered: 05/21/2019)
5/20/2019NOTICE OF SERVICE of Non-Parties Dennis Demont, Greg Slatter, Ph.D., Cecile Krejsa, Ph.D., and Peter Carbonaros Objections and Responses to Pharmacyclics Document Subpoena filed by Acerta Pharma B.V., Acerta Pharma LLC.(Dudash, Amy) (Entered: 05/20/2019)
5/20/2019NOTICE OF SERVICE of Pharmacyclics LLC's First Supplemental Responses and Objections to Defendant AstraZeneca Pharmaceuticals LP's Interrogatories (Nos. 1, 2, 5, 6 & 7) filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 05/20/2019)
5/20/2019NOTICE OF SERVICE of Defendants' Supplemental Responses to Plaintiff's Interrogatory Nos. 2, 12, and 15 filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam) (Entered: 05/20/2019)
5/17/2019REDACTED VERSION of 149 Notice to Take Deposition, by Pharmacyclics LLC. (Tigan, Jeremy) Modified on 5/17/2019 (nms). (Entered: 05/17/2019)
5/17/2019REDACTED VERSION of 148 Notice to Take Deposition, by Pharmacyclics LLC. (Tigan, Jeremy) Modified on 5/17/2019 (nms). (Entered: 05/17/2019)
5/17/2019SECOND REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of redacted version of DI # 148 and 149 . (nms) (Entered: 05/17/2019)
5/13/2019REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of redacted versions of DI # 148 and 149 . (nms) (Entered: 05/13/2019)
5/13/2019 NOTICE of Amended Subpoena for Andrew Crew, by Pharmacyclics LLC. (Tigan, Jeremy) Modified on 5/13/2019 (nms). (Entered: 05/13/2019)
5/9/2019CORRECTING ENTRY: The docket text for D.I. 152 has been amended to reflect the deponent is Ahmed Handy not Adam Weber. (nms) (Entered: 05/09/2019)
5/8/2019 NOTICE of Subpoenas to Maria Fardis, Jesse McGreivy, Francisco Salva, and Jac Wijkmans, by Pharmacyclics LLC. (Tigan, Jeremy) Modified on 5/9/2019 (nms). (Entered: 05/08/2019)
5/8/2019NOTICE to Take Deposition of Tjeerd Barf on a mutually agreed upon date filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 05/08/2019)
5/8/2019NOTICE to Take Deposition of Raquel Izumi on a mutually agreed upon date filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 05/08/2019)
5/8/2019NOTICE to Take Deposition of Erik Schrader on a mutually agreed upon date filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 05/08/2019)
5/8/2019NOTICE to Take Deposition of Allard Kaptein on a mutually agreed upon date filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 05/08/2019)
5/8/2019NOTICE to Take Deposition of Ahmed Handy on a mutually agreed upon date, filed by Pharmacyclics LLC.(Tigan, Jeremy) Modified on 5/9/2019 (nms). (Entered: 05/08/2019)
5/8/2019Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 5/8/2019. Local counsel present for plaintiff: J. Lyons. Local counsel present for defendants: A. Poff. (Court Reporter Heather Triozzi.) (crb) (Entered: 05/08/2019)
5/7/2019151
  • Order
ORAL ORDER: The Markman hearing scheduled for 5/8/2019, will begin at 9:00 am. Ordered by Judge Richard G. Andrews on 5/7/2019. (nms) (Entered: 05/07/2019)
5/2/2019150
  • Order
ORAL ORDER: Due to a potential scheduling conflict the parties are placed on notice that the Markman hearing scheduled for 5/8/2019, will take place as soon as the Court is available, which may be any time on 5/8/2019, or 5/9/2019. Counsel should be prepared to be available to appear on a 15 minute notice. Ordered by Judge Richard G. Andrews on 5/2/2019. (nms) (Entered: 05/02/2019)
5/1/2019[SEALED] NOTICE to Take Deposition of Defendants Acerta Pharma B.V. and Acerta Pharma LLC on June 25, 2019 filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 05/01/2019)
5/1/2019[SEALED] NOTICE to Take Deposition of Defendant AstraZeneca Pharmaceuticals LP on June 27, 2019 filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 05/01/2019)
4/26/2019 NOTICE of Second Amended Subpoena to Cara Cesario by Pharmacyclics LLC (Tigan, Jeremy) (Entered: 04/26/2019)
4/24/2019 NOTICE of Amended Subpoena by AbbVie Inc., Pharmacyclics LLC. (Attachments: # 1 Subpoena)(Tigan, Jeremy) Modified on 4/24/2019 (nms). (Entered: 04/24/2019)
4/24/2019NOTICE to Take Deposition of Todd Covey on a date that is mutually agreeable to the parties filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 04/24/2019)
4/24/2019 NOTICE of Subpoenas to Testify at a Deposition in a Civil Action by Pharmacyclics LLC (Tigan, Jeremy) (Entered: 04/24/2019)
4/24/2019 NOTICE of Amended Subpoenas by AbbVie Inc., Pharmacyclics LLC. (Attachments: # 1 Subpoena, # 2 Subpoena, # 3 Subpoena)(Tigan, Jeremy) Modified on 4/24/2019 (nms). (Entered: 04/24/2019)
4/23/2019NOTICE OF SERVICE of Deposition Subpoenas, filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibits 1-2)(Poff, Adam) Modified on 4/24/2019 (nms). (Entered: 04/23/2019)
4/23/2019SO ORDERED, re 137 STIPULATION TO EXTEND TIME to Submit Joint Claim Construction Brief to April 22, 2019. Signed by Judge Richard G. Andrews on 4/18/2019. (nms) (Entered: 04/23/2019)
4/22/2019Joint Appendix re 140 Joint Claim Construction Brief, by Pharmacyclics LLC. (Attachments: # 1 JA295-644)(Tigan, Jeremy) Modified on 4/23/2019 (nms). (Entered: 04/22/2019)
4/22/2019Joint Claim Construction Brief, filed by Pharmacyclics LLC. (Tigan, Jeremy) Modified on 4/23/2019 (nms). (Entered: 04/22/2019)
4/22/2019 NOTICE of Subpoenas, by AbbVie Inc., Pharmacyclics LLC, (Attachments: # 1 Tjeerd Barf Subpoena, # 2 Peter Carbonaro Subpoena, # 3 Cara Cesario Subpoena, # 4 Andrew Cooke Subpoena, # 5 Andrew Crew Subpoena, # 6 Dennis Demont Subpoena, # 7 HanQing Dong Subpoena, # 8 Lixin Feng Subpoena, # 9 Kenneth Foreman Subpoena, # 10 Ahmed Hamdy Subpoena, # 11 Raquel Izumi Subpoena, # 12 Qun-Sheng Ji Subpoena, # 13 Patricia Anne Johnson Subpoena, # 14 Allard Kaptein Subpoena, # 15 Cecile Krejsa Subpoena, # 16 Gilda Mak Subpoena, # 17 Mark Joseph Mulvihill Subpoena, # 18 Anthony Innocenzo Nigro Subpoena, # 19 Matthew OConnor Subpoena, # 20 Francisco Salva Subpoena, # 21 Greg Slatter Subpoena, # 22 Arno G. Steinig Subpoena, # 23 Kathryn M. Stolz Subpoena, # 24 Izabela Sujka Subpoena, # 25 Yingchuan Sun Subpoena, # 26 Brian Volk Subpoena, # 27 Qinghua Weng Subpoena, # 28 Douglas Werner Subpoena, # 29 Jac Wijkmans Subpoena, # 30 Robin Wilkes Subpoena)(Tigan, Jeremy) Modified on 4/23/2019 (nms). (Entered: 04/22/2019)
4/18/2019NOTICE OF SERVICE of Defendants Sur-Reply Claim Construction Brief filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam) (Entered: 04/18/2019)
4/18/2019 STIPULATION TO EXTEND TIME to Submit Joint Claim Construction Brief to April 22, 2019 - filed by Pharmacyclics LLC. (Tigan, Jeremy) (Entered: 04/18/2019)
4/12/2019 NOTICE of Subpoenas by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1-4)(Poff, Adam) (Entered: 04/12/2019)
4/2/2019NOTICE OF SERVICE of Pharmacyclics LLC's Reply Claim Construction Brief filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 04/02/2019)
4/1/2019 NOTICE of Amended Third Party Subpoena to Orion Jankowski, by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 4/1/2019 (nms). (Entered: 04/01/2019)
4/1/2019 NOTICE of Amended Third Party Subpoena to Kyle Elrod by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 4/1/2019 (nms). (Entered: 04/01/2019)
4/1/2019 NOTICE of Amended Third Party Subpoena to Douglas A. Jeffrey, by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 4/1/2019 (nms). (Entered: 04/01/2019)
3/25/2019NOTICE to Take Deposition of Eric V. Anslyn, Ph.D. on March 28, 2019 filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 03/25/2019)
3/22/2019Pro Hac Vice Attorney Robert Smyth for Acerta Pharma B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-00581-RGA, 1:17-cv-01582-RGA(ceg) (Entered: 03/22/2019)
3/20/2019NOTICE OF SERVICE of 1) Defendants Answering Claim Construction Brief; and 2) Declaration of Eric V. Anslyn, Ph.D. in Support of Defendants Answering Claim Construction Brief filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam) (Entered: 03/20/2019)
3/19/2019
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 129 MOTION for Pro Hac Vice Appearance of Attorney Robert Smyth, PhD., filed by Acerta Pharma LLC, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 3/19/2019. (nms) (Entered: 03/19/2019)
3/19/2019
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Robert Smyth, PhD. - filed by Acerta Pharma B.V., Acerta Pharma LLC. (Gorman, John) (Entered: 03/19/2019)
3/15/2019NOTICE OF SERVICE of Non-Party Dr. Maria Fardis's Supplemental Responses and Objections to Plaintiff's Subpoena re 121 Notice of Service filed by Acerta Pharma B.V., Acerta Pharma LLC.(Dudash, Amy) (Entered: 03/15/2019)
3/7/2019NOTICE to Take Deposition of Eric N. Jacobsen, Ph.D. on March 13, 2019 beginning at 9:00 a.m. filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam) (Entered: 03/07/2019)
3/6/2019NOTICE OF SERVICE of Non-Party Paula Franson Banniga's Supplemental Responses and Objections to Plaintiff's Document Subpoena, filed by Acerta Pharma B.V., Acerta Pharma LLC.(Dudash, Amy) Modified on 3/7/2019 (nms). (Entered: 03/06/2019)
3/5/2019NOTICE OF SERVICE of Deposition Subpoenas filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibits 1-8)(Poff, Adam) Modified on 3/6/2019 (nms). (Entered: 03/05/2019)
3/5/2019NOTICE OF SERVICE of Defendants' Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam) (Entered: 03/05/2019)
2/22/2019NOTICE OF SERVICE of Pharmacyclics LLC's Opening Claim Construction Brief filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 02/22/2019)
2/21/2019NOTICE OF SERVICE of Non-Party Paula Franson Banninga's Objections and Responses to Plaintiff Pharmacyclics LLC's Document Subpoena, filed by Acerta Pharma B.V., Acerta Pharma LLC.(Dudash, Amy) Modified on 2/21/2019 (nms). (Entered: 02/21/2019)
2/20/2019NOTICE OF SERVICE of Non-Party Maria Fardis's Responses and Objections to Plaintiff Pharmacyclics LLC's Document Subpoena, filed by Acerta Pharma B.V., Acerta Pharma LLC.(Dudash, Amy) Modified on 2/21/2019 (nms). (Entered: 02/20/2019)
2/19/2019NOTICE OF SERVICE of Objections of Non-Parties Stephen Chan and Jesse McGreivy to Document Subpoenas, filed by Acerta Pharma B.V., Acerta Pharma LLC.(Dudash, Amy) Modified on 2/21/2019 (nms). (Entered: 02/19/2019)
2/12/2019Pro Hac Vice Attorney James Kirkpatrick for AstraZeneca Pharmaceuticals LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) (Entered: 02/12/2019)
2/12/2019
  • Motion to Extend Time
SO ORDERED, re 118 STIPULATION TO EXTEND TIME for Claim Construction Briefing (*Reset Deadlines: Joint Claim Construction Brief due by 4/19/2019). Signed by Judge Richard G. Andrews on 2/12/2019. (nms) (Entered: 02/12/2019)
2/12/2019SO ORDERED, re 117 STIPULATION TO EXTEND TIME to Submit Joint Claim Chart to February 11, 2019. Signed by Judge Richard G. Andrews on 2/11/2019. (nms) (Entered: 02/12/2019)
2/11/2019Joint Claim Construction Chart, by Pharmacyclics LLC. (Attachments: # 1 Exhibit 1-3)(Tigan, Jeremy) Modified on 2/12/2019 (nms). (Entered: 02/11/2019)
2/11/2019 STIPULATION TO EXTEND TIME for Claim Construction Briefing to Various Dates - filed by Pharmacyclics LLC. (Tigan, Jeremy) (Entered: 02/11/2019)
2/8/2019 STIPULATION TO EXTEND TIME to Submit Joint Claim Chart to February 11, 2019 - filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam) (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to Michelle Xia by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms). (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to Erik J. Verner by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms). (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to Robert Rydzewski by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms). (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to Tarak Mody by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms). (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to Richard Miller by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms). (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to Tania Mahajan by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms). (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to David J. Loury by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms). (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to James Janc by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms). (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to Orion Jankowski by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms). (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to Leslie Holsinger by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms). (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to Bernie Hirschbein by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1 - Subpoena)(Poff, Adam) (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to Michael Green by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms). (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to Kyle Elrod by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms). (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to Wei Chen by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 2/11/2019 (nms). (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to Kareem Chehade by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 2/8/2019 (nms). (Entered: 02/08/2019)
2/8/2019 NOTICE of Third Party Subpoena to Joseph J. Buggy by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 2/8/2019 (nms). (Entered: 02/08/2019)
2/7/2019Amended NOTICE of Subpoena to Paula Franson by Pharmacyclics LLC (Tigan, Jeremy) (Entered: 02/07/2019)
2/6/2019SO ORDERED, re 99 STIPULATION TO EXTEND TIME to Submit the Joint Claim Chart to February 8, 2019. Signed by Judge Richard G. Andrews on 2/5/2019. (nms) (Entered: 02/06/2019)
2/5/2019 STIPULATION TO EXTEND TIME to Submit the Joint Claim Chart to February 8, 2019 - filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam) (Entered: 02/05/2019)
2/5/2019
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 98 MOTION for Pro Hac Vice Appearance of Attorney James Kirkpatrick, filed by AstraZeneca Pharmaceuticals LP. Signed by Judge Richard G. Andrews on 2/5/2019. (nms) (Entered: 02/05/2019)
2/4/2019
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney James Kirkpatrick - filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam) (Entered: 02/04/2019)
2/1/2019 NOTICE of Subpoenas, by Pharmacyclics LLC. (Tigan, Jeremy) Modified on 2/1/2019 (nms). (Entered: 02/01/2019)
1/25/2019NOTICE OF SERVICE of Pharmacyclics LLC's Responses and Objections to Defendants First Joint Set of Interrogatories (Nos. 7-21) filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 01/25/2019)
1/25/2019Pro Hac Vice Attorney Michael A. Morin for Pharmacyclics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) (Entered: 01/25/2019)
1/24/2019NOTICE OF SERVICE of Defendants' Amended Initial Disclosures filed by AstraZeneca Pharmaceuticals LP.(Kraman, Pilar) (Entered: 01/24/2019)
1/24/2019NOTICE OF SERVICE of Defendants' Disclosure of Proposed Claim Terms for Construction and Proposed Constructions filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam) (Entered: 01/24/2019)
1/23/2019NOTICE OF SERVICE of Plaintiff's Proposed Claim Terms for Construction filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 01/23/2019)
1/16/2019 NOTICE of Third Party Subpoena to Heleen Scheerens by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit 1)(Poff, Adam) Modified on 1/17/2019 (nms). (Entered: 01/16/2019)
1/14/2019
  • Order
SO ORDERED, re 91 STIPULATION and Proposed Order. Signed by Judge Richard G. Andrews on 1/11/2019. (nms) (Entered: 01/14/2019)
1/11/2019STIPULATION and Proposed Order - filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam) Modified on 1/11/2019 (nms). (Entered: 01/11/2019)
1/8/2019 NOTICE of Third Party Subpoena of Zhengying Pan, by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Kraman, Pilar) Modified on 1/9/2019 (nms). (Entered: 01/08/2019)
1/8/2019 NOTICE of Third Party Subpoena of Paul G. Grothaus, by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Kraman, Pilar) Modified on 1/9/2019 (nms). (Entered: 01/08/2019)
1/8/2019 NOTICE of Third Party Subpoena of Leland C. Burrill, by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Kraman, Pilar) Modified on 1/9/2019 (nms). (Entered: 01/08/2019)
1/8/2019 NOTICE of Third Party Subpoena of Keana C.K. Scott, by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Kraman, Pilar) Modified on 1/9/2019 (nms). (Entered: 01/08/2019)
1/8/2019 NOTICE of Third Party Subpoena of James T. Palmer, by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Kraman, Pilar) Modified on 1/9/2019 (nms). (Entered: 01/08/2019)
1/8/2019 NOTICE of Third Party Subpoena on Douglas A. Jeffery, by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit 1)(Kraman, Pilar) Modified on 1/9/2019 (nms). (Entered: 01/08/2019)
1/8/2019 NOTICE of Third Party Subpoena on Brian E. Schultz, by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit 1)(Kraman, Pilar) Modified on 1/9/2019 (nms). (Entered: 01/08/2019)
12/21/2018NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's Second Set of Requests for Production (Nos. 107-120) filed by AstraZeneca Pharmaceuticals LP.(Kraman, Pilar) (Entered: 12/21/2018)
12/12/2018NOTICE OF SERVICE of Pharmacyclics LLC's First Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and Pharmacyclics LLC's First Amended Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 12/12/2018)
12/5/2018NOTICE OF SERVICE of Defendants First Joint Set of Interrogatories to Pharmacyclics LLC filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam) (Entered: 12/05/2018)
11/26/2018NOTICE OF SERVICE of Defendants Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-20) filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam) (Entered: 11/26/2018)
11/21/2018NOTICE OF SERVICE of Pharmacyclics LLC's Second Set of Requests to Defendants for the Production of Documents and Things (Nos. 107-120) filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 11/21/2018)
11/20/2018
  • Order
ORDER Setting Mediation Conference: A Telephone Conference is set for 3/4/2019 at 10:45 AM before Judge Christopher J. Burke. Signed by Judge Christopher J. Burke on 11/20/2018. Associated Cases: 1:17-cv-01582-RGA, 1:18-cv-00581-RGA(dlb) (Entered: 11/20/2018)
10/26/2018Pro Hac Vice Attorney Lauren Sharkey for Pharmacyclics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) (Entered: 10/26/2018)
10/24/2018Pro Hac Vice Attorney Lesley M. Hamming for Pharmacyclics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) (Entered: 10/24/2018)
10/24/2018Pro Hac Vice Attorney Brenda L. Danek for Pharmacyclics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) (Entered: 10/24/2018)
10/23/2018
  • Order
ORDER Setting Mediation Conference: A Telephone Conference is set for 11/19/2018 at 10:15 AM before Judge Christopher J. Burke to discuss ADR. Signed by Judge Christopher J. Burke on 10/23/2018. Associated Cases: 1:17-cv-01582-RGA, 1:18-cv-00581-RGA(dlb) (Entered: 10/23/2018)
10/22/2018CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-01582-RGA, 1:18-cv-00581-RGA(cak) (Entered: 10/22/2018)
10/19/2018NOTICE OF SERVICE of Pharmacyclics LLC's Responses and Objections to Defendant AstraZeneca Pharmaceuticals LP's First Set of Interrogatories (Nos. 1-6) filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 10/19/2018)
10/17/2018Joint Status Report, by Pharmacyclics LLC. (Tigan, Jeremy) Modified on 10/18/2018 (nms). (Entered: 10/17/2018)
10/5/201874
  • Order
ORAL ORDER: In light of the reassignment of this matter the Court will adopt the Scheduling Order filed at D.I. 29 with the following modifications:(1) The case is now referred to a Magistrate Judge for the purpose of exploring ADR; (2) Should counsel find they are unable to resolve a discovery matter or other matters the parties involved shall contact chambers at (302) 573-4581; (3) The Status Conference set for November 1, 2018, is now CANCELLED. Should the parties wish to have a future conference set they will advise the Court accordingly; (4) The jury trial will be five days in length. Ordered by Judge Richard G. Andrews on 10/5/2018. (nms) (Entered: 10/05/2018)
10/3/2018
  • Motion to Consolidate
ORDER: The motions to consolidate (D.I. 49 in C.A. 17-1582-RGA; D.I. 12 in C.A. 18-581-RGA) and the motion for leave to amend answer, etc. (D.I. 56 in C.A. 17-1582-RGA) are DENIED. Further, the scheduling order (D.I. 29 in C.A. 17-1582-RGA) is MODIFIED to reflect a jury trial will be five days long. Signed by Judge Richard G. Andrews on 10/3/2018. Associated Cases: 1:17-cv-01582-RGA, 1:18-cv-00581-RGA(nms) (Entered: 10/03/2018)
10/1/2018NOTICE OF SERVICE of Pharmacyclics LLC's First Set of Interrogatories to Defendants (Nos. 1-20) filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 10/01/2018)
9/19/2018NOTICE OF SERVICE of Defendant AstraZeneca Pharmaceuticals LP's First Set of Interrogatories to Pharmacyclics filed by AstraZeneca Pharmaceuticals LP.(Kraman, Pilar) (Entered: 09/19/2018)
9/6/2018Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:17-cv-01582-RGA, 1:18-cv-00581-RGA (rjb) (Entered: 09/06/2018)
8/27/2018 NOTICE of Subpoena Duces Tecum to Peter R. Young by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit A, # 2 Certificate of Service)(Kraman, Pilar) (Entered: 08/27/2018)
8/27/2018 NOTICE of Subpoena Duces Tecum to Jill M. Spoerke by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit A, # 2 Certificate of Service)(Kraman, Pilar) (Entered: 08/27/2018)
8/27/2018 NOTICE of Subpoena Duces Tecum to Rohan V. Mendonca by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit A, # 2 Certificate of Service)(Kraman, Pilar) (Entered: 08/27/2018)
8/27/2018 NOTICE of Subpoena Duces Tecum to Lee A. Honigberg by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit A, # 2 Certificate of Service)(Kraman, Pilar) (Entered: 08/27/2018)
8/20/2018
  • Motion to Amend Answer
REPLY BRIEF re 56 MOTION For Leave to Amend Answer, Affirmative Defenses, and Counterclaims and Joint Additional Parties, filed by Acerta Pharma B.V., Acerta Pharma LLC, AstraZeneca Pharmaceuticals LP. (Kraman, Pilar) Modified on 9/6/2018 (nms). (Entered: 08/20/2018)
8/17/2018 NOTICE of Subpoenas by AstraZeneca Pharmaceuticals LP (Attachments: # 1 Exhibit A-Subpoena to Stacie A. Dalrymple, # 2 Exhibit B-Subpoena to Shyr-Jiann Li, # 3 Exhibit C-Subpoena to Paul A. Sprengeler)(Poff, Adam) (Entered: 08/17/2018)
8/6/2018DECLARATION of G. Sobolski re 63 Answering Brief in Opposition, by Pharmacyclics LLC. (Attachments: # 1 Exhibits)(Tigan, Jeremy) Modified on 9/6/2018 (nms). (Entered: 08/06/2018)
8/6/2018
  • Motion to Amend Answer
ANSWERING BRIEF in Opposition re 56 MOTION For Leave to Amend Answer, Affirmative Defenses, and Counterclaims and Joint Additional Parties, filed by Pharmacyclics LLC. Reply Brief due date per Local Rules is 8/13/2018. (Tigan, Jeremy) Modified on 9/6/2018 (nms). (Entered: 08/06/2018)
8/3/2018
  • Order
ORDER approving 61 STIPULATION and Proposed Order Extending Time. Signed by Judge Eduardo C. Robreno on 8/3/2018. (nmf) Modified on 9/6/2018 (nms). (Entered: 08/03/2018)
8/2/2018 STIPULATION TO EXTEND TIME for Defendants to file a reply brief in support of their Motion to Amend to August 20, 2018 - filed by Pharmacyclics LLC. (Tigan, Jeremy) (Entered: 08/02/2018)
7/27/2018
  • Motion to Consolidateby Δ
REPLY BRIEF re 49 MOTION to Consolidate Cases filed by Acerta Pharma B.V., Acerta Pharma LLC, AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit A through C, # 2 Certificate of Service)(Kraman, Pilar) (Entered: 07/27/2018)
7/18/2018
  • Order
ORDER approving 58 STIPULATION TO EXTEND TIME 1) in C.A. 17-1582-ER for Plaintiff Pharmacyclics to respond to Defendants Motion to Amend [D.I. 56]; and (2) the deadlines in both C.A. 17-1582-ER and C.A. 18-581-ER for AstraZeneca and Acerta to file a reply brief in support, ORDER re-setting briefing schedule re 56 MOTION to Amend/Correct 12 Answer to Complaint, Counterclaim and Join Additional Parties : (Answering Brief due 8/6/2018.) ; re 49 MOTION to Consolidate Cases: (Reply Brief due 7/27/2018.) Signed by Judge Eduardo C. Robreno on 7/18/2018. (nmf) (Entered: 07/18/2018)
7/18/2018STIPULATION and Proposed Order to Extend Time - filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam) Modified on 9/6/2018 (nms). (Entered: 07/18/2018)
7/16/2018OPENING BRIEF in Support re 56 MOTION For Leave to Amend Answer, Affirmative Defenses, and Counterclaims and Joint Additional Parties, filed by Acerta Pharma B.V., Acerta Pharma LLC, AstraZeneca Pharmaceuticals LP.Answering Brief/Response due date per Local Rules is 7/30/2018. (Attachments: # 1 Amended Answer, # 2 Exhibit B, # 3 Exhibit C, # 4 Certificate of Service)(Poff, Adam) Modified on 9/6/2018 (nms). (Entered: 07/16/2018)
7/16/2018
  • Motion to Amend Answer
MOTION For Leave to Amend Answer, Affirmative Defenses, and Counterclaims and Joint Additional Parties - filed by Acerta Pharma B.V., Acerta Pharma LLC, AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Proposed Order, # 2 Certificate of Service)(Poff, Adam) Modified on 9/6/2018 (nms). (Entered: 07/16/2018)
7/13/2018
  • Motion to Consolidateby Π
ANSWERING BRIEF in Opposition re 49 MOTION to Consolidate Cases filed by Pharmacyclics LLC.Reply Brief due date per Local Rules is 7/20/2018. (Attachments: # 1 Exhibits A-B)(Tigan, Jeremy) (Entered: 07/13/2018)
7/10/2018
  • Order
ORDER approving 52 STIPULATION TO EXTEND TIME. Reset Briefing Schedule: The deadline for defendants to serve their initial invalidity contentions is extended through and including 7/6/2018. Deadline for plaintiff to respond to 49 MOTION to Consolidate Cases is extended through and including 7/13/2018. Signed by Judge Eduardo C. Robreno on 7/10/2018. (crb) (Entered: 07/10/2018)
7/9/2018Case Reassigned to Judge Eduardo C. Robreno of the Eastern District of Pennsylvania (in lieu of Vacant Judgeship). Please include the initials of the Judge (ER) after the case number on all documents filed. Associated Cases: 1:17-cv-01582-ER, 1:18-cv-00581-ER (rjb) (Entered: 07/09/2018)
7/6/2018NOTICE OF SERVICE of Defendants Initial Invalidity Contentions filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam) (Entered: 07/06/2018)
7/2/2018 STIPULATION TO EXTEND TIME for defendant to serve their initial invalidity contentions and for plaintiff to respond to defendants' Motion to Consolidate to July 6, 2018 and July 13, 2018, respectively - filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam) (Entered: 07/02/2018)
6/18/2018
  • Order
SO ORDERED re (51 in 17-cv-1582-VAC-MPT, 14 in 18-cv-581-VAC-MPT) STIPULATION and Proposed Order to Extend Time. Signed by Judge Mary Pat Thynge on 6/18/18. Associated Cases: 1:18-cv-00581-VAC-MPT, 1:17-cv-01582-VAC-MPT(cak) Modified on 9/6/2018 (nms). (Entered: 06/18/2018)
6/14/2018STIPULATION and Proposed Order to Extend Time - filed by AbbVie Inc., Pharmacyclics LLC. (Tigan, Jeremy) Modified on 9/6/2018 (nms). (Entered: 06/14/2018)
6/12/2018 OPENING BRIEF in Support re 49 MOTION to Consolidate Cases filed by Acerta Pharma B.V., Acerta Pharma LLC, AstraZeneca Pharmaceuticals LP.Answering Brief/Response due date per Local Rules is 6/26/2018. (Poff, Adam) (Entered: 06/12/2018)
6/12/2018
  • Motion to Consolidateby Δ
MOTION to Consolidate Cases - filed by Acerta Pharma B.V., Acerta Pharma LLC, AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Rule 7.1.1 Certification, # 2 Text of Proposed Order, # 3 Certificate of Service)Motions referred to Mary Pat Thynge.(Poff, Adam) (Entered: 06/12/2018)
6/1/2018NOTICE OF SERVICE of Pharmacyclics LLC's Infringement Contentions filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 06/01/2018)
5/17/2018NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's First Set of Requests for Production (Nos. 1-106) filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam) (Entered: 05/17/2018)
5/10/2018NOTICE OF SERVICE of Pharmacyclics LLC's Responses and Objections to Defendant AstraZeneca Pharmaceuticals LP's First Requests for Production of Documents (Nos. 1-132) filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 05/10/2018)
4/19/2018
  • Order
SO ORDERED re 44 Stipulated Protective Order. Signed by Judge Mary Pat Thynge on 4/19/18. (cak) (Entered: 04/19/2018)
4/18/2018 PROPOSED Protective Order, by Pharmacyclics LLC. (Tigan, Jeremy) Modified on 9/6/2018 (nms). (Entered: 04/18/2018)
4/17/2018SO ORDERED re 43 STIPULATION TO EXTEND TIME for the parties to file a Proposed Protective Order to April 18, 2018 filed by Pharmacyclics LLC. So Ordered by Judge Mary Pat Thynge on 4/17/18. (cak) (Entered: 04/17/2018)
4/16/2018 STIPULATION TO EXTEND TIME for the parties to file a Proposed Protective Order to April 18, 2018 - filed by Pharmacyclics LLC. (Tigan, Jeremy) (Entered: 04/16/2018)
4/10/2018NOTICE OF SERVICE of Pharmacyclics LLC's First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-106) filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 04/10/2018)
4/10/2018
  • Motion to Extend TimeGranted
ORDER re 38 Granting STIPULATION TO EXTEND TIME by which the parties may file a Proposed Protective Order to April 16, 2018 filed by Pharmacyclics LLC. Signed by Judge Mary Pat Thynge on 4/10/18. (kjk) (Entered: 04/10/2018)
4/9/2018NOTICE OF SERVICE of Pharmacyclics LLC's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 04/09/2018)
4/9/2018NOTICE OF SERVICE of Defendants [Joint] Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam) (Entered: 04/09/2018)
4/5/2018 STIPULATION TO EXTEND TIME by which the parties may file a Proposed Protective Order to April 16, 2018 - filed by Pharmacyclics LLC. (Tigan, Jeremy) (Entered: 04/05/2018)
4/3/2018NOTICE OF SERVICE of Defendant AstraZeneca Pharmaceuticals LPs First Requests for Production of Documents (Nos. 1-132) filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam) (Entered: 04/03/2018)
4/2/2018
  • Motion to Extend Time
SO ORDERED re 35 STIPULATION TO EXTEND TIME for the parties to serve Paragraph 3 Disclosures to April 9, 2018 filed by AstraZeneca Pharmaceuticals LP. Signed by Judge Mary Pat Thynge on 4/2/18. (cak) (Entered: 04/02/2018)
4/2/2018SO ORDERED re 34 STIPULATION TO EXTEND TIME for the parties to file a Proposed Protective Order to April 9, 2018 filed by Pharmacyclics LLC. Signed by Judge Mary Pat Thynge on 4/2/18. (cak) (Entered: 04/02/2018)
4/2/2018NOTICE OF SERVICE of Pharmacyclics LLC's Initial Disclosures Identifying Defendants' Accused Products and Plaintiff's Asserted Patents filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 04/02/2018)
4/2/2018 STIPULATION TO EXTEND TIME for the parties to serve Paragraph 3 Disclosures to April 9, 2018 - filed by AstraZeneca Pharmaceuticals LP. (Kraman, Pilar) (Entered: 04/02/2018)
3/29/2018 STIPULATION TO EXTEND TIME for the parties to file a Proposed Protective Order to April 9, 2018 - filed by Pharmacyclics LLC. (Tigan, Jeremy) (Entered: 03/29/2018)
3/20/2018
  • Motion to Extend Time
SO ORDERED re 33 STIPULATION TO EXTEND TIME by which the parties may file a Proposed Protective Order to April 2, 2018 filed by Pharmacyclics LLC. Signed by Judge Mary Pat Thynge on 3/20/18. (cak) (Entered: 03/20/2018)
3/19/2018 STIPULATION TO EXTEND TIME by which the parties may file a Proposed Protective Order to April 2, 2018 - filed by Pharmacyclics LLC. (Tigan, Jeremy) (Entered: 03/19/2018)
3/15/2018NOTICE OF SERVICE of Defendants Acerta Pharma B.V. and Acerta Pharma LLC's Initial Disclosures filed by Acerta Pharma B.V., Acerta Pharma LLC.(Dudash, Amy) (Entered: 03/15/2018)
3/15/2018NOTICE OF SERVICE of Pharmacyclics LLC's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Pharmacyclics LLC.(Tigan, Jeremy) (Entered: 03/15/2018)
3/15/2018NOTICE OF SERVICE of Defendant AstraZeneca's Initial Disclosures filed by AstraZeneca Pharmaceuticals LP.(Poff, Adam) (Entered: 03/15/2018)
3/8/2018
  • Scheduling Order
SCHEDULING ORDER: Joinder of Parties due by 7/16/2018. Fact Discovery completed by 6/12/2019. Opening Expert Reports due by 7/17/2019. Rebuttal Expert Reports due by 8/28/2019. Expert Discovery due by 10/25/2019. A Status Conference is set for 11/1/2018 at 11:00 AM before Judge Mary Pat Thynge Status Report due by 10/17/2018. Dispositive Motions due by 11/8/2019. Answering Brief due 12/6/2019. Reply Brief due 12/20/2019. Claim Construction Opening Brief due by 2/20/2019. Claim Construction Answering Brief due by 3/13/2019. Claim Construction Reply Brief due by 3/27/2019. Claim Construction Surreply Brief due by 4/10/2019. A Markman Hearing is set for 5/8/2019 at 9:00 AM before Judge Mary Pat Thynge. Proposed Pretrial Order due by 5/21/2020. A Final Pretrial Conference is set for 6/2/2020 at 09:00 AM before Vacant Judgeship (2017). A Jury Trial is set for 6/15/2020 at 09:30 AM before Vacant Judgeship (2017). Signed by Judge Mary Pat Thynge on 3/8/18. (cak) (Entered: 03/08/2018)
3/8/2018NOTICE requesting Clerk to remove Jessica S. Richard as co-counsel. Reason for request: no longer associated with Williams & Connolly LLP. (Poff, Adam) (Entered: 03/08/2018)
3/6/2018CORRECTING ENTRY: DI 28 deleted from the docket and added as an exhibit to DI 27 (cak) (Entered: 03/06/2018)
3/5/2018
  • Motion
PROPOSED ORDER // Scheduling Order by Pharmacyclics LLC. (Tigan, Jeremy) (Additional attachment(s) added on 3/6/2018: # 1 Table of Proposed Dates) (cak). (Entered: 03/05/2018)
3/1/2018NOTICE requesting Clerk to remove Raymond N. Nimrod, Matthew A. Traupman, Stephen A. Swedlow, and Amanda K. Antons, Ph.D. as co-counsel.. (Tigan, Jeremy) (Entered: 03/01/2018)
2/23/2018Minute Entry for proceedings held before Judge Mary Pat Thynge - Telephone Conference re: Rule 16 Scheduling held on 2/23/2018; Counsel shall file a final scheduling order; ATTENDEES: - PLTFF. - J. Tigan, Esq.; M. Moran, Esq.; DEFT. - A. Dudash, Esq.; J. Gorman, Esq,; O. Bernson, Esq.; A. Poff, Esq.; D. Berl, Esq.; (Court Reporter V. Gunning.) (kjk) (Entered: 02/26/2018)
2/16/2018
  • Motionby Π
PROPOSED ORDER // Scheduling Order re 24 Order Setting Teleconference, by Pharmacyclics LLC. (Tigan, Jeremy) (Entered: 02/16/2018)
2/7/201824
  • Order
ORAL ORDER Setting Rule 16 Scheduling Teleconference: Plaintiff's counsel to initiate the call. The Rule 16 Scheduling Telephone Conference set for 2/13/18 at 1:00 PM Eastern Time with Judge Thynge has been rescheduled to 2/23/2018 at 1:00 PM Eastern Time. The Proposed Scheduling Order shall now be due on or before 2/16/18. Ordered by Judge Mary Pat Thynge on 2/7/18. (cak) (Entered: 02/07/2018)
1/30/2018
  • Answer
ANSWER to 12 Answer to Complaint, and Counterclaims, by Pharmacyclics LLC.(Tigan, Jeremy) Modified on 5/2/2019 (nms). (Entered: 01/30/2018)
1/26/2018Pro Hac Vice Attorney Gregory K. Sobolski for Pharmacyclics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) (Entered: 01/26/2018)
1/25/201822
  • Order
ORAL ORDER Setting Teleconference: The Rule 16 scheduling teleconference with Judge Thynge, set for 1/29/18 at 2:00 PM Eastern Time and proposed scheduling order due date of 1/25/18, has been rescheduled to 2/13/2018 at 1:00 PM Eastern Time. The proposed scheduling order shall now be due on or before 2/8/18. Plaintiff's counsel shall initiate the teleconference call. Ordered by Judge Mary Pat Thynge on 1/25/18. (cak) (Entered: 01/25/2018)
1/22/2018Pro Hac Vice Attorney Olga Berson for Acerta Pharma B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) (Entered: 01/22/2018)
1/19/2018
  • Motion to Appear Pro Hac ViceGranted
SO ORDERED granting 21 Motion to Appear Pro Hac Vice of Lesley M. Hamming to represent plaintiff Pharmacyclics LLC. Signed by Judge Mary Pat Thynge on 1/19/18. (cak) (Entered: 01/19/2018)
1/19/2018
  • Motion to Appear Pro Hac ViceGranted
SO ORDERED granting 20 Motion to Appear Pro Hac Vice of Attorney Michael A. Morin, David P. Frazier, Brenda L. Danek, Gregory K. Sobolski, Lauren K. Sharkey, and Kamilah Alexander - filed by Pharmacyclics LLC. Signed by Judge Mary Pat Thynge on 1/19/18. (cak) (Entered: 01/19/2018)
1/19/2018
  • Motion to Appear Pro Hac Viceby Π
MOTION for Pro Hac Vice Appearance of Attorney Lesley M. Hamming - filed by Pharmacyclics LLC. Motions referred to Mary Pat Thynge.(Tigan, Jeremy) (Entered: 01/19/2018)
1/18/2018
  • Motion to Appear Pro Hac Viceby Π
MOTION for Pro Hac Vice Appearance of Attorney Michael A. Morin, David P. Frazier, Brenda L. Danek, Gregory K. Sobolski, Lauren K. Sharkey, and Kamilah Alexander - filed by Pharmacyclics LLC. Motions referred to Mary Pat Thynge.(Tigan, Jeremy) (Entered: 01/18/2018)
1/18/2018
  • Order
Order Setting Telephonic Scheduling Conference: A Rule 16 Scheduling Teleconference is set for 1/29/2018 at 3:00 PM Eastern Time before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 1/18/18. (cak) (Entered: 01/18/2018)
1/16/2018Pro Hac Vice Attorney John V. Gorman for Acerta Pharma B.V.,Acerta Pharma LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) (Entered: 01/16/2018)
1/16/2018Pro Hac Vice Attorney Dov P. Grossman for AstraZeneca Pharmaceuticals LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) (Entered: 01/16/2018)
1/12/2018
  • Motion to Appear Pro Hac ViceGranted
SO ORDERED granting 18 Motion to Appear Pro Hac Vice of Attorney John V. Gorman, Eric Kraeutler, and Olga Berson, Ph.D. - filed by Acerta Pharma B.V., Acerta Pharma LLC. Signed by Judge Mary Pat Thynge on 1/12/18. (cak) (Entered: 01/12/2018)
1/12/2018
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney John V. Gorman, Eric Kraeutler, and Olga Berson, Ph.D. - filed by Acerta Pharma B.V., Acerta Pharma LLC. Motions referred to Mary Pat Thynge.(Marston, David) (Entered: 01/12/2018)
1/10/2018Pro Hac Vice Attorney Kevin D. Hoagland-Hanson for AstraZeneca Pharmaceuticals LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (nmg) (Entered: 01/10/2018)
1/10/2018
  • Motion to Appear Pro Hac ViceGranted
SO ORDERED granting 16 Motion to Appear Pro Hac Vice of Attorney Dov P. Grossman, Jessica S. Richard, Kevin D. Hoagland-Hanson, and Galina I. Fomenkova - filed by AstraZeneca Pharmaceuticals LP. Signed by Judge Mary Pat Thynge on 1/10/18. (cak) (Entered: 01/10/2018)
1/9/2018 NOTICE of Entry of Appearance of Teagan Gregory, Esquire of Williams & Connolly LLP as additional counsel for defendant, AstraZeneca Pharmaceuticals LP by AstraZeneca Pharmaceuticals LP (Poff, Adam) (Entered: 01/09/2018)
1/9/2018
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Dov P. Grossman, Jessica S. Richard, Kevin D. Hoagland-Hanson, and Galina I. Fomenkova - filed by AstraZeneca Pharmaceuticals LP. Motions referred to Mary Pat Thynge.(Poff, Adam) (Entered: 01/09/2018)
1/9/2018NOTICE of Appearance by Amy Michele Dudash on behalf of Acerta Pharma B.V., Acerta Pharma LLC (Dudash, Amy) (Entered: 01/09/2018)
1/9/2018 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Acerta Pharma B.V., Acerta Pharma LLC filed by Acerta Pharma B.V., Acerta Pharma LLC. (nmg) (Entered: 01/09/2018)
1/9/2018 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC, for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam) (Entered: 01/09/2018)
1/9/2018
  • Answer
ANSWER to 1 Complaint, and COUNTERCLAIMS against Pharmacyclics LLC by AstraZeneca Pharmaceuticals LP.(Poff, Adam) Modified on 9/6/2018 (nms). (Entered: 01/09/2018)
12/12/2017Pro Hac Vice Attorney Stanley E. Fisher for AstraZeneca Pharmaceuticals LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) (Entered: 12/12/2017)
12/8/2017Pro Hac Vice Attorney David I. Berl for AstraZeneca Pharmaceuticals LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) (Entered: 12/08/2017)
12/6/2017
  • Motion to Appear Pro Hac ViceGranted
SO ORDERED granting 11 Motion to Appear Pro Hac Vice of Attorneys David I. Berl and Attorney Stanley E. Fisher - filed by AstraZeneca Pharmaceuticals LP. Signed by Judge Mary Pat Thynge on 12/6/17. (cak) (Entered: 12/06/2017)
12/6/2017
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney David I. Berl and Attorney Stanley E. Fisher - filed by AstraZeneca Pharmaceuticals LP. Motions referred to Mary Pat Thynge.(Poff, Adam) (Entered: 12/06/2017)
11/27/2017Set/Reset Answer Deadlines: Answer for All Defendants now due 1/9/18. (cak) (Entered: 11/27/2017)
11/27/2017
  • Motion to Extend Time
SO ORDERED re 10 Joint STIPULATION TO EXTEND TIME for Defendants to answer, move or otherwise respond to Plaintiff's Complaint to January 9, 2018. Signed by Judge Mary Pat Thynge on 11/27/17. (cak) (Entered: 11/27/2017)
11/27/2017STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Plaintiff's Complaint to January 9, 2018 - filed by AstraZeneca Pharmaceuticals LP. (Poff, Adam) Modified on 9/6/2018 (nms). (Entered: 11/27/2017)
11/9/2017 SUMMONS Returned Executed by Pharmacyclics LLC. Acerta Pharma LLC served on 11/6/2017, answer due 11/27/2017. (Dellinger, Megan) (Entered: 11/09/2017)
11/9/2017 SUMMONS Returned Executed by Pharmacyclics LLC. Acerta Pharma B.V. served on 11/6/2017, answer due 11/27/2017. (Dellinger, Megan) (Entered: 11/09/2017)
11/9/2017
  • Motion to Appear Pro Hac ViceGranted
SO ORDERED granting 7 Motion to Appear Pro Hac Vice of Attorney Raymond N. Nimrod - filed by Pharmacyclics LLC. Signed by Judge Mary Pat Thynge on 11/9/17. (cak) (Entered: 11/09/2017)
11/9/2017
  • Motion to Appear Pro Hac Viceby Π
MOTION for Pro Hac Vice Appearance of Attorney Raymond N. Nimrod - filed by Pharmacyclics LLC. Motions referred to Mary Pat Thynge.(Dellinger, Megan) (Entered: 11/09/2017)
11/8/2017
  • Motion to Appear Pro Hac ViceGranted
SO ORDERED granting 6 Motion to Appear Pro Hac Vice of Attorney Matthew A. Traupman, Stephen A. Swedlow, and Amanda K. Antons, Ph.D. to represent plaintiff Pharmacyclics. Signed by Judge Mary Pat Thynge on 11/8/17. (cak) (Entered: 11/08/2017)
11/8/2017***NOTE: If the parties jointly consent to Chief Magistrate Judge Thynges jurisdiction to conduct all proceedings in this case, then the Pretrial Conference and Trial will be presided over by Judge Thynge consistent with 28 U.S.C. § 636. Otherwise, in accordance with the District Court's procedures for "Assignment of Cases to Visiting Judges" (issued May 26, 2017 and available on the District Court's website), upon the filing of a case-dispositive motion (e.g., a motion to dismiss, a motion for judgment on the pleadings, a motion for summary judgment, or initiation of the claim construction process in a patent case), VAC cases will be reassigned to a visiting District Judge, and any further dates in the Scheduling Order, including the Pretrial Conference and Trial dates, may be adjusted dependent on the availability of the visiting District Judge. (cak) (Entered: 11/08/2017)
11/8/2017CASE REFERRED to Magistrate Judge Mary Pat Thynge. (This matter has been assigned to the Vacant Judgeship and referred to a Magistrate Judge for handling through case-dispositive motions. The Magistrate Judge has full authority permitted by law to manage this matter, including entering schedules through trial, deciding non-dispositive matters and making recommendations as to the resolution of dispositive matters. Litigants and counsel are reminded that they have the option of consenting to the Magistrate Judge to handle the case in full, including trial, or consenting to having a particular motion resolved by the Magistrate Judge.) Motions referred to Mary Pat Thynge.(rjb) (Entered: 11/08/2017)
11/8/2017Case Assigned to Vacant Judgeship (2017). Please include initials of VAC after the case number on all documents filed. (rjb) (Entered: 11/08/2017)
11/8/2017
  • Motion to Appear Pro Hac Viceby Π
MOTION for Pro Hac Vice Appearance of Attorney Matthew A. Traupman, Stephen A. Swedlow, and Amanda K. Antons, Ph.D. - filed by Pharmacyclics LLC. (Dellinger, Megan) (Entered: 11/08/2017)
11/6/2017 SUMMONS Returned Executed by Pharmacyclics LLC. AstraZeneca Pharmaceuticals LP served on 11/6/2017, answer due 11/27/2017. (Dellinger, Megan) (Entered: 11/06/2017)
11/3/2017Summons Issued with Magistrate Consent Notice attached as to Acerta Pharma B.V. on 11/3/2017; Acerta Pharma LLC on 11/3/2017; AstraZeneca Pharmaceuticals LP on 11/3/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) (Entered: 11/03/2017)
11/3/2017 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Pharmacyclics LLC filed by Pharmacyclics LLC. (ceg) (Entered: 11/03/2017)
11/3/2017Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,079,908 B2; 9,139,591 B2; 9,556,182 B2. (ceg) (Entered: 11/03/2017)
11/3/2017Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) (Entered: 11/03/2017)
11/3/2017
  • Complaint
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Acerta Pharma B.V., Acerta Pharma LLC, AstraZeneca Pharmaceuticals LP - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2259696.) - filed by Pharmacyclics LLC. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(ceg) (Entered: 11/03/2017)